Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures … Read more
Lifecare AS (LIFE) - Net Assets
Latest net assets as of September 2025: Nkr-6.66 Million NOK
Based on the latest financial reports, Lifecare AS (LIFE) has net assets worth Nkr-6.66 Million NOK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr85.47 Million) and total liabilities (Nkr92.13 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr-6.66 Million |
| % of Total Assets | -7.79% |
| Annual Growth Rate | 52.21% |
| 5-Year Change | 455.12% |
| 10-Year Change | N/A |
| Growth Volatility | 142.64 |
Lifecare AS - Net Assets Trend (2015–2024)
This chart illustrates how Lifecare AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lifecare AS (2015–2024)
The table below shows the annual net assets of Lifecare AS from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr73.98 Million | +11.32% |
| 2023-12-31 | Nkr66.45 Million | +20.28% |
| 2022-12-31 | Nkr55.25 Million | +127.88% |
| 2021-12-31 | Nkr24.25 Million | +81.94% |
| 2020-12-31 | Nkr13.33 Million | -15.30% |
| 2019-12-31 | Nkr15.73 Million | -29.26% |
| 2018-12-31 | Nkr22.24 Million | +1045.89% |
| 2017-12-31 | Nkr-2.35 Million | -377.11% |
| 2016-12-31 | Nkr848.46K | -49.65% |
| 2015-12-31 | Nkr1.69 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lifecare AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 128914400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Nkr82.44 Million | 110.78% |
| Other Comprehensive Income | Nkr1.00K | 0.00% |
| Other Components | Nkr8.04 Million | 10.81% |
| Total Equity | Nkr74.41 Million | 100.00% |
Lifecare AS Competitors by Market Cap
The table below lists competitors of Lifecare AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Environmental Control Corp
PINK:YBCN
|
$407.52K |
|
M2M GROUP
BC:M2M-GROUP
|
$407.79K |
|
GRUPUL INDUSTRIAL ELECTROCONTACT S.A.
RO:ECT
|
$408.26K |
|
Bank of Labor Bancshares Inc
PINK:BHDB
|
$408.29K |
|
Computacenter PLC
LSE:CCC
|
$407.06K |
|
MW Trade S.A.
WAR:MWT
|
$407.05K |
|
FIRSTENERGY (FE7.SG)
STU:FE7
|
$406.89K |
|
GOLD FIELDS - Dusseldorf Stock Exchang
DU:EDGA
|
$406.46K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lifecare AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 66,402,426 to 74,410,000, a change of 8,007,574 (12.1%).
- Net loss of 71,757,000 reduced equity.
- New share issuances of 106,625,000 increased equity.
- Other comprehensive income increased equity by 1,000.
- Other factors decreased equity by 26,861,426.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-71.76 Million | -96.43% |
| Share Issuances | Nkr106.62 Million | +143.29% |
| Other Comprehensive Income | Nkr1.00K | +0.0% |
| Other Changes | Nkr-26.86 Million | -36.1% |
| Total Change | Nkr- | 12.06% |
Book Value vs Market Value Analysis
This analysis compares Lifecare AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.07x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.30x to 0.07x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | Nkr0.30 | Nkr0.40 | x |
| 2016-12-31 | Nkr0.15 | Nkr0.40 | x |
| 2017-12-31 | Nkr-0.42 | Nkr0.40 | x |
| 2018-12-31 | Nkr2.75 | Nkr0.40 | x |
| 2019-12-31 | Nkr1.94 | Nkr0.40 | x |
| 2020-12-31 | Nkr1.48 | Nkr0.40 | x |
| 2021-12-31 | Nkr2.70 | Nkr0.40 | x |
| 2022-12-31 | Nkr4.79 | Nkr0.40 | x |
| 2023-12-31 | Nkr7.17 | Nkr0.40 | x |
| 2024-12-31 | Nkr5.83 | Nkr0.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lifecare AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -96.43%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2367.44%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.51x
- Recent ROE (-96.43%) is above the historical average (-138.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -444.70% | -192.44% | 1.71x | 1.35x | Nkr-7.66 Million |
| 2016 | -588.64% | -309.46% | 0.87x | 2.19x | Nkr-5.08 Million |
| 2017 | 0.00% | -622.56% | 0.46x | 0.00x | Nkr-3.20 Million |
| 2018 | -39.54% | -252.25% | 0.15x | 1.05x | Nkr-11.02 Million |
| 2019 | -41.67% | -316.87% | 0.12x | 1.11x | Nkr-8.13 Million |
| 2020 | -20.57% | -163.88% | 0.11x | 1.10x | Nkr-4.07 Million |
| 2021 | -65.48% | -4894.06% | 0.01x | 1.33x | Nkr-18.30 Million |
| 2022 | -30.97% | -104.56% | 0.24x | 1.24x | Nkr-23.12 Million |
| 2023 | -53.10% | -269.43% | 0.15x | 1.30x | Nkr-41.90 Million |
| 2024 | -96.43% | -2367.44% | 0.03x | 1.51x | Nkr-79.20 Million |
Industry Comparison
This section compares Lifecare AS's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $141,007,003
- Average return on equity (ROE) among peers: -45.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lifecare AS (LIFE) | Nkr-6.66 Million | -444.70% | N/A | $407.52K |
| Gentian Diagnostics AS (GENT) | $174.77 Million | -14.19% | 0.21x | $40.48 Million |
| Medistim ASA (MEDI) | $236.86 Million | 29.68% | 0.42x | $229.18 Million |
| Observe Medical Asa (OBSRV) | $11.39 Million | -152.45% | 4.62x | $1.80 Million |